FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication Quarterly Medical Device Warning Letters Update: January March 2025 FDA Compliance for Peptide Therapy and BPC 157 Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York